Blocking the Horizon-Amgen deal will be worse for pharma than for biotech, says Mizuho’s Jared Holz

May 19, 2023
Blocking the Horizon-Amgen deal will be worse for pharma than for biotech, says Mizuho’s Jared HolzBlocking the Horizon-Amgen deal will be worse for pharma than for biotech, says Mizuho’s Jared Holz
Share This

Jared Holz, Mizuho healthcare sector strategist, joins ‘Fast Money’ to discuss merger and acquisition crackdowns in the biotech space, government regulation in the space, and more.

Latest Mizuho News

Mizuho Financial Group launches strategic technology and operations center in Pune

Mizuho Financial Group launches strategic technology and operations center in Pune

May 21, 2026
A lot of concern around consumer spending ahead of retail earnings, says Mizuho’s Bellinger

A lot of concern around consumer spending ahead of retail earnings, says Mizuho’s Bellinger

May 19, 2026
Why biotechnology stocks have more room to run

Why biotechnology stocks have more room to run

May 12, 2026

Mizuho news from around the globe

back-to-top-blue